Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Gordon Robb
Person

Gordon Robb

Tracked across 3 events · 22 articles · First seen Feb 03, 2026 · Last active Feb 20, 2026

Sentiment
37
Attention
2
Events
3
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (3)
2 50
Tech
Aspiring Clinical Trial for Haemorrhagic Stroke
Gordon Robb, a stroke survivor, is participating in the Aspiring clinical trial to test the effectiveness of clopidogrel in preventing future strokes. His experience highlights the importance of recognizing unusual stroke symptoms.
Feb 13, 2026 · 8 articles
2 30
Business
ESGold Appoints Galen Carson to Advisory Board
Gordon Robb, CEO of ESGold, expressed satisfaction with formalizing Galen Carson's advisory role, acknowledging his contributions to ESGold's transformation and growth.
Feb 17, 2026 · 7 articles
2 30
Business
ESGold Expands Montauban Gold-Silver Survey
Gordon Robb, CEO of ESGold, commented on the significance of the expanded ANT survey, highlighting its importance in defining the full scale of the Montauban project and its potential for new discoveries.
Feb 03, 2026 · 7 articles
Relationships (1)
ESGold Chief Executive Officer ↔ Gordon Robb Gordon Robb is the Chief Executive Officer of ESGold.
NEWSDESK
Track Gordon Robb live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.